Promore Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 29, 2022 at 07:28 am EST
Promore Pharma AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was SEK 5.35 million compared to SEK 6.11 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.11 a year ago.
For the nine months, net loss was SEK 19.85 million compared to SEK 21.08 million a year ago. Basic loss per share from continuing operations was SEK 0.33 compared to SEK 0.49 a year ago.